Total Payments
$10,789
2024 Payments
$1,426
Companies
42
Transactions
733
Medicare Patients
1,324
Medicare Billing
$168,795

Payment Breakdown by Category

Food & Beverage$10,732 (99.5%)
Education$56.85 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,732 726 99.5%
Education $56.85 7 0.5%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,788 103 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,458 94 $0 (2024)
Amgen Inc. $878.28 58 $0 (2024)
Lilly USA, LLC $783.76 64 $0 (2024)
Merck Sharp & Dohme LLC $745.10 72 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $638.52 37 $0 (2023)
PFIZER INC. $542.17 27 $0 (2024)
SANOFI-AVENTIS U.S. LLC $488.93 29 $0 (2023)
EISAI INC. $397.50 26 $0 (2022)
GlaxoSmithKline, LLC. $334.46 22 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,426 79 PFIZER INC. ($186.17)
2023 $1,497 87 Novo Nordisk Inc ($244.29)
2022 $858.31 55 Novo Nordisk Inc ($152.15)
2021 $781.09 45 Novo Nordisk Inc ($213.21)
2020 $834.70 58 Novo Nordisk Inc ($220.01)
2019 $1,895 157 Novo Nordisk Inc ($248.55)
2018 $1,802 136 AstraZeneca Pharmaceuticals LP ($390.36)
2017 $1,695 116 AstraZeneca Pharmaceuticals LP ($354.32)

All Payment Transactions

733 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/24/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.28 General
Category: Cardiovascular and Metabolism
12/18/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $22.76 General
Category: NEUROLOGY
11/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $11.31 General
Category: RESPIRATORY
11/19/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $23.87 General
Category: Endocrinology
11/19/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $21.30 General
Category: PSYCHIATRY
11/18/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.99 General
Category: Diabetes
11/07/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $22.44 General
Category: Inflammation/Rare Disease
11/05/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $23.81 General
Category: Diabetes Care
11/04/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $26.61 General
Category: VACCINES
10/29/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $25.89 General
Category: Psychology/Psychiatric
10/28/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $14.50 General
Category: GASTROENTEROLOGY
10/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $11.30 General
Category: RESPIRATORY
10/18/2024 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $14.67 General
Category: RESPIRATORY
10/17/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $24.39 General
Category: Endocrinology
10/09/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $26.30 General
Category: Biological
10/09/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $1.83 General
Category: Biological
10/01/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.99 General
Category: PSYCHIATRY
09/30/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $18.79 General
Category: Endocrinology
09/26/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $24.21 General
Category: Diabetes Care
09/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.22 General
Category: RESPIRATORY
09/18/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $17.78 General
Category: GASTROENTEROLOGY
09/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $17.48 General
Category: UROLOGY
09/16/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $17.27 General
Category: Inflammation
08/28/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.64 General
Category: RESPIRATORY
08/27/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.00 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 377 543 $125,404 $52,099
2022 12 357 497 $113,739 $49,353
2021 9 315 418 $90,887 $41,062
2020 9 275 367 $72,855 $26,280
Total Patients
1,324
Total Services
1,825
Medicare Billing
$168,795
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 114 243 $57,348 $22,844 39.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 78 78 $18,876 $10,054 53.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 45 67 $21,172 $7,622 36.0%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 16 16 $9,504 $4,214 44.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 12 12 $5,400 $1,882 34.9%
90662 Influenza vaccine split virus, preservative free Office 2023 21 21 $1,632 $1,500 91.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 13 13 $4,719 $1,271 26.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 17 $2,703 $1,167 43.2%
G0008 Administration of influenza virus vaccine Office 2023 22 22 $1,530 $688.16 45.0%
G0009 Administration of pneumococcal vaccine Office 2023 16 16 $880.00 $467.43 53.1%
96372 Injection of drug or substance under skin or into muscle Office 2023 12 20 $1,100 $216.79 19.7%
83036 Hemoglobin a1c level Office 2023 12 18 $540.00 $171.36 31.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 90 199 $62,884 $26,546 42.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 71 71 $17,182 $9,258 53.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 49 73 $17,228 $6,318 36.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 17 17 $7,650 $2,456 32.1%
90662 Influenza vaccine split virus, preservative free Office 2022 26 27 $1,944 $1,775 91.3%
G0008 Administration of influenza virus vaccine Office 2022 27 28 $1,540 $817.42 53.1%
0124A Fee covid-19 vac 13 res Office 2022 15 15 $1,200 $561.12 46.8%
0054A Adm sarscv2 30mcg trs-sucr b Office 2022 13 13 $1,040 $524.73 50.5%
G0009 Administration of pneumococcal vaccine Office 2022 15 16 $880.00 $487.59 55.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 11 11 $1,056 $323.50 30.6%
90471 Administration of vaccine Office 2022 11 13 $715.00 $151.52 21.2%
83036 Hemoglobin a1c level Office 2022 12 14 $420.00 $134.11 31.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 67 109 $34,444 $15,249 44.3%

About Dr. Manar Harmouch, M.D

Dr. Manar Harmouch, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902242563.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manar Harmouch, M.D has received a total of $10,789 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 733 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,732).

As a Medicare-enrolled provider, Harmouch has provided services to 1,324 Medicare beneficiaries, totaling 1,825 services with total Medicare billing of $168,795. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

Products in Payments

  • FARXIGA (Drug) $1,280
  • Ozempic (Drug) $600.55
  • JARDIANCE (Drug) $518.94
  • JANUVIA (Drug) $421.30
  • Victoza (Drug) $331.32
  • TRADJENTA (Drug) $286.52
  • Belviq (Drug) $283.24
  • Prolia (Biological) $274.36
  • FREESTYLE LIBRE 3 (Device) $259.49
  • Aimovig (Biological) $219.85
  • TRELEGY ELLIPTA (Drug) $218.30
  • Wegovy (Drug) $217.23
  • TRULICITY (Drug) $216.34
  • NURTEC ODT (Drug) $209.61
  • EMGALITY (Drug) $191.81
  • Otezla (Drug) $180.31
  • ENTRESTO (Drug) $176.92
  • VRAYLAR (Drug) $170.29
  • SOLIQUA (Drug) $167.25
  • CAPLYTA (Drug) $163.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Houston